Fulminant and accelerated presentation of dermatomyositis in two previously healthy young adult males: A potential role for endotheliotropic viral infection

Journal of Cutaneous Pathology

Volumn 36, Issue 8, 2009, Pages 853-858

  Magro, Cynthia M ^a   Iwenofu, Obiajulu H ^b   Kearns, Mary J ^c   Nuovo, Gerard J ^b   Dyrsen, Molly E ^a   Segal, Jeremy P ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; EOSIN; HEMATOXYLIN; IMMUNOGLOBULIN; LEVOFLOXACIN; METHOTREXATE; METHYLPREDNISOLONE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; STEROID; VIRUS RNA;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; CLINICAL FEATURE; COLON ULCER; CYTOPATHOGENIC EFFECT; DERMATOMYOSITIS; DISEASE COURSE; ELECTROMYOGRAPHY; ENDOTHELIUM; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; IMMUNOCOMPETENCE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG BIOPSY; LUNG PARENCHYMA; MALE; MALIGNANT ATROPHIC PAPULOSIS; MIXED INFECTION; MYALGIA; PARVOVIRUS; PLASMAPHERESIS; PNEUMONIA; QUADRIPLEGIA; RASH; RESPIRATORY FAILURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SKIN BIOPSY; SKIN CULTURE; VIRUS INFECTION;

ADULT; AUTOIMMUNE DISEASES; BIOPSY; DERMATOMYOSITIS; FATAL OUTCOME; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HUMANS; LUNG; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RNA, VIRAL; SKIN;

EID: 67650663236     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2008.01171.x     Document Type: Article

References (51)

1. Crowson AN, Magro CM. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol 1996 27 : 15.
2. Kovacs SO, Kovacs C. Dermatomyositis. J Am Acad Dermatol 1998 39 : 899.
3. Callen JP. Dermatomyositis. Lancet 2000 355 : 53.
4. Santmyire-Rosenberger B, Dugan EM. Skin involvement in dermatomyositis. Curr Opin Rheumatol 2003 15 : 714.
5. Magro CM, Crowson AN. The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus. J Cutan Pathol 1997 24 : 543.
6. Greenberg SA, Amato AA. Uncertainties in the pathogenesis of adult dermatomyositis. Curr Opin Neurol 2004 17 : 359.
7. Kissel JT, Halterman RK, Rammohan KW, et al. The relationship of complement mediated microvasculopathy to the histological features and clinical duration of disease in dermatomyositis. Arch Neurol 1991 48 : 26.
8. Kissel JT, Mendell JR, Rammohan KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986 314 : 329.
9. Silver RM, Maricq HR. Childhood dermatomyositis: serial microvascular studies. Pediatrics 1989 83 : 278.
10. Crowson AN. Superficial and deep perivascular dermatitis. In Barnhill RL, Crowson AN, eds. Textbook of dermatopathology. 2nd ed. New York : McGraw-Hill, 2004 92.
11. Crowson AN, Magro CM, Dawood MR. A causal role for parvovirus B19 infection in adult dermatomyosistis and other autoimmune syndromes. J Cutan Pathol 2000 27 : 505.
12. Finkel TH, Torok TJ, Ferguson PJ, et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or etiological agent? Lancet 1994 43 : 1255.
13. Lewkonia RM, Horne D, Dawood MR. Juvenile dermatomyositis in a child infected with human parvovirus B19. Clin Infect Dis 1995 21 : 430.
14. Kalish RA, Knowf AN, Gary W, Canoso JJ. Lupus-like presentation of human parvovirus B19 infection. J Rheumatol 1992 19 : 169.
15. Trepani S, Ermini M, Falcini H. Human parvovirus B19 infection: its relationship with systemic lupus erythematosus. Semin Arthritis Rheum 1999 28 : 319.
16. Chassagne PL, Mejjad O, Gourmelen O, et al. Exacerbation of systemic lupus erythematosus during human parvovirus B19 infection. Br J Rheumatol 1993 32 : 158.
17. Glickstein SL. Lupus-like presentation of human parvovirus B19 infection. J Rheumatol 1982 19 : 1253.
18. Magro CM, Nuovo G, Crowson AN, et al. Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma. J Cutan Pathol 2004 31 : 43.
19. Agnello V, Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 1997 40 : 2007.
20. Meyer MF, Hellmich B, Kotterba S, et al. Cytomegalovirus infection in systemic necrotizing vasculitis: causative agent or opportunistic infection. Rheumatol Int 2000 20 : 35.
21. Nuovo GJ. PCR in situ hybridization: protocols and applications, 3rd edn. New York : Lippincott-Raven, 1997.
22. Magro CM, Dyrsen ME. The use of C3d and C4d in immunohistochemistry on formalin fixed paraffin embedded tissue in the diagnostic assessment of inflammatory skin disease. J Am Acad Dermatol (in press).
23. Selva-O'Callaghan A, Labrador-Horrillo M, Munoz-Gall X. Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients. Lupus 2005 14 : 534.
24. Takizawa H, Shiga J, Moroi Y, et al. Interstitial lung disease in dermatomyositis: clinicopathologic study. J Rheumatol 1987 25 : 1336.
25. Burton F, Myer D, Myer AR. Pulmonary disease in polymyositis/ dermatomyositis. Semin Arthritis Rheum 1984 14 : 60.
26. Tazelaar HD, Viggiano RW, Pickersgill J, et al. Interstitial lung disease in polymyositis and dermatomyositis: clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990 141 : 727.
27. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis- associated interstitial lung disease. Am J Respir Crit Care Med 2001 164 : 1182.
28. Fujisawa T, Suda T, Nakamura Y, et al. Differences in clinical features and prognosis in interstitial lung disease between polymyositis and dermatomyositis. J Rheumatol 2005 32 : 58.
29. Perez-Galan MJ, Sanchez-Gonzalez MD, Garcia-Sanchez A, et al. Dermatomyositis with catastrophic pulmonary involvement. Lupus 2006 15 : 901.
30. Nobutoh T, Kohda M, Doi Y, et al. An autopsy case of dermatomyositis with rapidly progressive diffuse alveolar damage. J Dermatol 1998 25 : 32.
31. Naggai Y, Ishikawa O, Miyachi Y. Pneumomediastinum and subcutaneous emphysema associated with fatal interstitial pneumonia in dermatomyositis. J Dermatol 1997 24 : 482.
32. Enoki T, Nakagami T, Murakami A, et al. A case of dermatomyositis with severe retinopathy in a patient who died of acute interstitial pneumonia. Nippon Ganka Gakki Zasshi 1997 101 : 441.
33. Yang CH, Wu TS, Chiu CT. Chronic hepatitis B reactivation: a word of caution regarding the use of systemic corticosteroid therapy. Br J Dermatol 2007 157 : 587.
34. Magro CM, Crowson AN, Ferri C. Cytomegalovirus-associated vasculopathy and scleroderma sans inclusion body change. Hum Pathol 2007 38 : 42.
35. Czartoski T, Liu C, Koelle D, et al. Fulminant acyclovir-resistant herpes simplex type 2 hepatitis in an immunocompetent woman. J Clin Microbiol 2006 44 : 1584.
36. Fahy RJ, Crouser E, Pacht ER. Herpes simplex type 2 causing fulminant hepatic failure. South Med J 2000 93 : 1216.
37. Farr RW, Short S, Weissman D. Fulminant hepatitis during herpes simplex virus infection in apparently immunocompetent adults: report of two cases and review of literature. Clin Infect Dis 1997 24 : 1191.
38. Tsao H, Busam K, Barnhill RL, et al. Lesions resembling malignant atrophic papulosis in a patient with dermatomyositis. J Am Acad Dermatol 1997 36 : 317.
39. Morita Y, Sakuta T, Nagasu H, et al. Bilateral ureteral stenosis and duodenal perforation in a patient with dermatomyositis. Mod Rheumatol 2007 15 : 54.
40. Degos R, Delort J, Tricot R. Dermatite papulosquameuse atrophiante. Bull Soc Fr Dermatol Syphiligr 1942 49 : 148.
41. Doutre MS, Beylot C, Bioulac P, et al. Skin lesions resembling malignant atrophic papulosis in lupus erythematosus. Dermatologica 1987 175 : 45.
42. Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988 25 : 151.
43. Brown KE, Young NS. Parvovirus B19 in human disease. Annu Rev Med 1997 48 : 59.
44. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993 262 : 114.
45. Cooling LL, Koerner TA, Naides SJ. Multiple glycosphingolipids determine the tissue tropism of parvovius B19. J Infect Dis 1995 172 : 1198.
46. Cherin P, Piette JC, Wechsler B, et al. Intravenous gammaglobulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients. J Rheumatol 1994 21 : 1092.
47. Lang BA, Laxer RM, Murphy G, et al. Treatment of dermatomyositis with intravenous gammaglobulin. Am J Med 1991 91 : 169.
48. Collet E, Dalac S, Maerens B, et al. Juvenile dermatomyositis: treatment with intravenous gammaglobulin. Br J Dermatol 1994 130 : 231.
49. Sansome A, Dubowitz V. Intravenous immunoglobulin in juvenile dermatomyositis-four year review of nine cases. Arch Dis Child 1995 72 : 25.
50. Dalakas MC, Illa I, Dambrosia JM, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment of dermatomyositis. N Engl J Med 1993 329 : 1993.
51. Wenzel J, Schmidt R, Proelss J, Zahn S, Bieber T, Tüting T. Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis. Clin Exp Dermatol 2006 31 : 576.